Teva Pharma (TEVA) PT Lowered to $14 at Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Teva Pharma (TEVA) Gains as Billionaire Blavatnik Considers Buying Large Stake
November 6, 2017 6:41 AM ESTBeaten-down Israeli pharmaceutical stock Teva Pharma (NYSE: TEVA) is gaining 2% in pre-open trade Monday following reports over the weekend from Globes that billionaire Len Blavatnik is considering taking a large stake in the company. The report said Blavatnik may be contemplating buying Allergan's (NYSE: AGN) 10% stake.
... MoreTeva Pharma (TEVA) PT Lowered to $13 at Goldman Sachs
November 6, 2017 5:28 AM ESTGoldman Sachs lowered its price target on Teva Pharma (NYSE: TEVA) to $13.00 (from $18.00) while maintaining a Neutral rating.
Analyst Jami Rubin says significant cost restructuring is required for Teva to stabilize. The analyst expects the equity to remain under pressure until the... More
Top five unique options volume: FB SBUX FL GE TEVA
November 3, 2017 9:56 AM EDTTop five unique options volume: FB SBUX FL GE TEVA
... MoreDeutsche Bank Downgrades Teva Pharma (TEVA) to Hold
November 3, 2017 5:54 AM EDTDeutsche Bank downgraded Teva Pharma (NYSE: TEVA) from Buy to Hold with a price target of $14.00 (from $22.00).
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $11.23 yesterday.
... MoreTeva Pharma (TEVA) PT Slashed to $10 at Cantor Fitzgerald
November 2, 2017 1:39 PM EDTCantor Fitzgerald analyst Louise Chen lowered her price target on Teva Pharma (NYSE: TEVA) to $10.00 (from $17.00) while maintaining a Neutral rating following Q3 miss and lower guide.
Chen thinks the company has some meaningful headwinds which need to be addressed before the... More
Teva Pharma (TEVA) Plunges to Fresh Low, Down 16%
November 2, 2017 9:33 AM EDTTeva Pharma (NYSE: TEVA) Plunges to Fresh Low, Down 16%
... MoreUPDATE: Teva Pharma (TEVA) Misses Q3 EPS by 4c, Q4 Guidance Comes in Light
November 2, 2017 7:00 AM EDT(Updated - November 2, 2017 7:05 AM EDT)
Teva Pharma (NYSE: TEVA) reported Q3 EPS of $1.00, $0.04 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $5.61 billion versus the consensus estimate of $5.62... More
